Cerus (CERS) Income from Continuing Operations (2010 - 2026)
Cerus (CERS) posted Income from Continuing Operations of 2982000.0 for Q2 2026, down 80.95% sequentially from 1648000.0 in Q1 2026, and up 47.82% YoY from 2017297.59 in Q2 2025.
Cerus (CERS) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Cerus has reported Income from Continuing Operations for 17 years, with the latest figure at 2982000.0 in Q2 2026.
- Quarterly Income from Continuing Operations rose 47.82% year-over-year to 2982000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 5697000.0 (up 61.83% YoY) and the FY2025 annual result came in at 14500000.0, up 14.5% from the prior year.
- Income from Continuing Operations fell to 2982000.0 in Q2 2026 per CERS's latest filing, from 1648000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 5815000.0 in Q4 2023 and troughed at 15641000.0 in Q1 2023.
- A 5-year average of 5596500.0 and a median of 5745000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations sank 370.54% in 2022, then soared 216.18% in 2023.
- Over 5 years, Income from Continuing Operations stood at 5005000.0 in 2022, then jumped by 216.18% to 5815000.0 in 2023, then slumped by 75.24% to 1440000.0 in 2024, then sank by 172.71% to 1047000.0 in 2025, then slumped by 184.81% to 2982000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 2982000.0, 1648000.0, and 1047000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | -2.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.98 Mn |
| Mar 31, 2026 | -1.65 Mn |
| Dec 31, 2025 | -2.18 Mn |
| Sep 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -5.72 Mn |
| Mar 31, 2025 | -7.72 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | -2.93 Mn |
| Jun 30, 2024 | -5.78 Mn |
| Mar 31, 2024 | -9.69 Mn |
| Dec 31, 2023 | -1.39 Mn |
| Sep 30, 2023 | -7.29 Mn |
| Jun 30, 2023 | -13.33 Mn |
| Mar 31, 2023 | -15.64 Mn |
| Dec 31, 2022 | -14.38 Mn |
| Sep 30, 2022 | -8.52 Mn |
| Jun 30, 2022 | -8.40 Mn |
| Mar 31, 2022 | -12.28 Mn |
| Dec 31, 2021 | 2.55 Mn |
| Sep 30, 2021 | -12.44 Mn |